Read more
April 2023
Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April…
Read more
April 2023
$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…
Read more
March 2023
JACC Review Topic of the Week. In this review the authors aim to summarize the role of PCAT in cardiac…
Read more
March 2023
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
Read more
March 2023
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…
Read more
February 2023
Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…
Read more
January 2023
BHF-funded researchers are paving the way towards future breakthroughs in heart disease research. Here are 5 big questions we’re helping…
Read more
December 2022
“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what…
